Compounds > profenamine
Page last updated: 2024-10-26

profenamine and Idiopathic Parkinson Disease

profenamine has been researched along with Idiopathic Parkinson Disease in 6 studies

profenamine: was heading 1972-94 (see under PHENOTHIAZINES 1972-90); use PHENOTHIAZINES to search ETHOPROPAZINE 1972-94
profenamine : A member of the class of phenothiazines that is phenothiazine in which the hydrogen attached to the nitrogen is substituted by a 2-(diethylamino)propyl group. An antimuscarinic, it is used as the hydrochloride for the symptomatic treatment of Parkinson's disease.

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GILLHESPY, RO1
DOSHAY, LJ1
CONSTABLE, K1
AGATE, FJ1
SOBUE, I1
IVES, ER1
ZIEGLER, DK1
TORRES, F1
BOVET, D1
DUREL, P1
LONGO, V1
LEBLOND, S1
PICHETTE, R1

Other Studies

6 other studies available for profenamine and Idiopathic Parkinson Disease

ArticleYear
Lysivane in the treatment of Parkinsonism.
    Edinburgh medical journal, 1953, Volume: 60, Issue:8

    Topics: Antipsychotic Agents; Heterocyclic Compounds; Parkinson Disease; Parkinsonian Disorders; Phenothiazi

1953
Ethopropazine (parsidol) hydrochloride in treatment of paralysis agitans; posology, method of administration, and effects.
    Journal of the American Medical Association, 1956, Feb-04, Volume: 160, Issue:5

    Topics: Cardiovascular Agents; Muscle Relaxants, Central; Parkinson Disease; Phenothiazines; Salts

1956
Parsidol in the treatment of Parkinson's syndrome.
    Bulletin of the Los Angeles Neurological Society, 1956, Volume: 21, Issue:2

    Topics: Antipsychotic Agents; Cardiovascular Agents; Muscle Relaxants, Central; Parkinson Disease; Phenothia

1956
Parsidol in the treatment of parkinsonism.
    Neurology, 1955, Volume: 5, Issue:3

    Topics: Antipsychotic Agents; Parkinson Disease; Parkinsonian Disorders; Phenothiazines

1955
[Antagonism of dibenzothiazine derivatives (diparcol, parsidol, phenergan) towards the central effects of nicotine; correspondence with clinical experimentation in Parkinson's disease].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1950, Volume: 144, Issue:7-8

    Topics: Empirical Research; Histamine Antagonists; Nicotine; Parkinson Disease; Parkinsonian Disorders; Phen

1950
[Trial treatment of Parkinson's disease].
    Laval medical, 1951, Volume: 16, Issue:2

    Topics: Diphenhydramine; Parkinson Disease; Parkinsonian Disorders; Phenothiazines

1951